Neurology & Cognitive Research
Mild Cognitive Impairment (MCI)
Mild Cognitive Impairment (MCI) is a condition marked by noticeable changes in memory and thinking abilities that are greater than normal aging but do not yet interfere significantly with daily life. CenExel is committed to advancing innovative clinical research focused on early diagnosis, prevention, and treatment strategies for cognitive decline.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Research for Mild Cognitive Impairment
CenExel conducts specialized clinical trials focused on Mild Cognitive Impairment and early-stage cognitive decline. Our experienced research teams collaborate with leading sponsors and healthcare professionals to evaluate promising therapies designed to improve memory, cognition, and overall quality of life for aging populations.
Conditions Covered
Cognitive Conditions We Research
Our neurology research sites support a broad range of cognitive and neurodegenerative conditions through advanced clinical studies and patient-focused care.
- Mild Cognitive Impairment (MCI)
- Early Alzheimer’s Disease
- Memory Loss
- Age-Related Cognitive Decline
- Dementia
- Vascular Cognitive Impairment
- Parkinson’s Disease Cognitive Changes
- Cognitive Dysfunction
Our Approach
Why Sponsors Choose CenExel for MCI Research
CenExel delivers scientific expertise, advanced patient recruitment strategies, and high-quality data execution to support successful Mild Cognitive Impairment clinical trials.
01
Cognitive Assessment Expertise
Experienced teams utilizing advanced cognitive testing and diagnostic methodologies.
02
Early-Stage Patient Recruitment
Strong access to diverse patient populations for early intervention studies.
03
Neurology Research Network
Integrated clinical research infrastructure across multiple specialized sites.
04
High-Quality Trial Execution
Consistent delivery of accurate data, patient retention, and regulatory compliance.
Phase Coverage
Supported Cognitive Research Trial Phases
CenExel supports early and late-phase Mild Cognitive Impairment studies — from proof-of-concept and biomarker-driven trials through Phase IV post-market research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Cognitive Research Task Force
CenExel supports a wide range of neurology and cognitive research studies focused on memory disorders, cognitive decline, and age-related neurological conditions across diverse patient populations.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
